131 - Validation of Analytical Methods (S9E11)

All right, welcome back. For today's deep dive,
we have a fascinating set of materials to unpack.
It's all about, well, how we know if our tests
are actually giving us reliable results. Exactly.
It's all about trust, isn't it? And particularly
this time, we're zeroing in on analytical method
validation in the pharmaceutical industry. Yeah,
the stuff that underpins basically every decision
in drug development, right? Absolutely. You know,
we've got excerpts from books on drug development,
some key regulatory guidelines, and other materials
you sent over. Yeah, a really interesting mix.
Yeah. And I think our mission here is to sort
of demystify this whole topic. I mean, method
validation can get pretty technical, right? Oh,
definitely. But it's so crucial. And it has such
a huge impact in the real world. So we want to
break it down, make it accessible without getting
bogged down in jargon. Exactly. So let's start
with the basics. Where does this validation process
even begin? And why is it so important? Like,
why do we care so much about making sure our
tests are reliable? Well, I'd say it starts right
at the beginning, when you're designing the analytical
method itself. OK, at the design phase. Right.
But the why is really about, as I said, trust.
Every decision we make in drug development and
quality control, it all relies on data from analytical
tests. Right. So validation is like, the foundation.
It's what gives us that confidence that the results
we're seeing are actually accurate and consistent.
Without it, well, we're basically making decisions
in the dark. Yeah, that's a scary thought. So
it's about making sure the tests, the tools we're
using to analyze drugs are actually measuring
what they're supposed to measure. and doing it
consistently. Precisely, because if a method
isn't validated, we just can't be sure if the
results are real. I mean, think about the consequences.
You could have incorrect dosing information in
a clinical trial. Oh, wow. Or even worse, you
could end up releasing a drug that's substandard
or even dangerous. Right. Yeah, that's a huge
deal. It is. And for you, as someone who wants
to be well -informed, understanding validation
is so important. It's about knowing that the
data we're using to make these crucial decisions
is solid. It's like cutting through all the noise,
making sure the information is actually good.
Exactly. So once we have a method designed, what
are the things we actually look at to validate
it? I know there are a bunch of parameters mentioned
in the materials. Yeah, there are. So let's break
those down one by one. What about specificity?
What does that mean in this context? OK, so specificity
is all about making sure the method is really
only measuring what we want it to measure. the
analyte, which is usually the drug itself. And
we need to make sure it's not picking up signals
from other stuff that might be present in the
sample. OK, so what kind of stuff are we talking
about? Well, it could be impurities that form
during the manufacturing process or even during
storage. Or it could be degradation products
of the drug itself. Or even the inactive ingredients,
the stuff that makes up the tablet or the capsule.
We call that the matrix. The matrix, right. Got
it. So specificity is about making sure we're
not fooled by any of those other things. We want
to be absolutely sure that the signal we're seeing
is coming from the drug and nothing else. Right.
So it's like if we're testing a tablet to see
how much the active ingredient is in it, we want
to make sure our method is only measuring that
ingredient and not getting confused by the fillers
or biners or whatever else is in the pill. You
got it. It's about having a truly selective method.
Okay, that makes sense. And then we have accuracy.
I feel like that one's a bit more intuitive.
It's about making sure we're getting the right
answer, right? Yeah, you're on the right track.
Accuracy is about how close our test results
are to the true value, the actual amount of analyte
in the sample. And we often demonstrate this
by using reference standards, samples where we
know exactly how much of the drug is present,
and we see how well our method can measure it.
And typically, accuracy is expressed as a percentage
recovery. So if we expect to find 10 milligrams,
and our method consistently measures, say, between
9 .8 and 10 .2 milligrams. Oh, that would be
a good indication of good accuracy. OK. So accuracy
is like hidden the bull's eye, and then there's
precision, which I always get these two confused,
but they're not the same thing, are they? No,
they're definitely distinct, though closely related.
Precision is about how close multiple measurements
are to each other. OK. So it's not about whether
the average is exactly right, that's accuracy.
Precision is about the consistency of the method.
And there are a few different levels of precision
we look at. OK, yeah, break those down for me.
Sure. So the first one is repeatability. And
this is the precision we see when the same analyst,
using the same equipment, runs the test on the
same sample multiple times all in a short period
of time. So like back to back to back same everything.
Exactly. It's how consistent the results are
under these really tightly controlled ideal conditions.
It's sort of the baseline level of precision.
OK, got it. And then we take it up a notch, right?
Right. So the next level is intermediate precision.
And this is where we start to introduce some
real world variability. OK, how so? Well, we
might have different analysts running the test,
or we might use different pieces of equipment
within the same lab, or even run the test on
different days. Right, things that would normally
happen in a lab setting. Exactly. And this helps
us understand how robust the method is to these
normal variations that occur within a single
lab. So it's still within the same lab, but we're
just making it a bit more Realistic. Exactly.
Then we have reproducibility, which, as you said,
takes it to the next level by involving different
labs altogether. Right. So now we're talking
about, like, if a method is going to be transferred
from a research lab to a manufacturing facility
or maybe even between different companies. Exactly.
Reproducibility is about seeing how consistent
the results are when the method is used in different
places. And interestingly, the ICH Q2R1 guideline,
which is kind of the Bible for analytical method
validation, Yeah, ICH, that comes up all the
time in these materials. It does, and for good
reason. Anyway, it mentions that if you've really
nailed down reproducibility, you might not even
need to worry about intermediate precision. Oh!
Yeah. But in practice, particularly when you're
transferring a method, the receiving lab will
usually do their own intermediate precision studies,
and both labs will generate reproducibility data
just to be absolutely sure everything is consistent
across locations. That makes a lot of sense.
So we've covered Specificity, accuracy, precision.
What about sensitivity? Our sources mentioned
things like detection limit and quantitation
limit. Can you explain those? Yeah, those are
key parameters, especially when we're dealing
with really small amounts of the analyte. So
the detection limit, or LOD, is the lowest concentration
of analyte that we can reliably detect. We can
say it's there, but we might not be able to accurately
measure how much of it there is. OK, so it's
like we know we're picking up a signal, but it's
maybe too faint. to get a precise reading. That's
a good analogy. It's about the sensitivity of
the method. And then the quantitation limit,
or LOQ, is a step up from that. It's the lowest
concentration we can not only detect, but also
quantify with acceptable accuracy and precision.
So it's like, LOD is about knowing something
is there, and LOQ is about being able to say,
OK, there's this much of it. Precisely. So LOQ
is really important for things like measuring
the amount of active ingredient in a drug product,
while LOD might be more relevant for detecting
impurities, which we usually want to keep at
very low levels. Got it. So those are all about
sensitivity. What about linearity and range?
What are those referred to? Well, linearity is
about how the response of the method changes
as the concentration of the analyte changes.
OK. So ideally, we want the response to be directly
proportional to the concentration. Think of it
like a straight line on a graph. The signal goes
up in a nice linear fashion as the concentration
increases and the range is simply the interval
of concentrations over which we've demonstrated
that the method is linear, accurate, and precise.
So we're not just checking linearity at a single
point but over a range of concentrations that
we might expect to encounter. Exactly. We need
to know the method is reliable whether we're
looking at a high dose of the drug or a very
low concentration of an impurity. That makes
sense. And then there's robustness. What does
that mean in the context of analytical methods?
Robustness is all about how well the method can
handle small changes in the conditions. Like,
what happens if the pH of a solution is slightly
off or the temperature isn't exactly what it
should be? Right, things happen in the real world.
They do. So a robust method will still give you
accurate and precise results even with these
minor variations. So it's kind of like... how
resilient the method is to the imperfections
of everyday lab work. Exactly. It's a measure
of its reliability in the face of real -world
variability. And finally, we have system suitability.
which is really all about making sure our equipment
is up to the task. System suitability. Yeah,
I was wondering about that one. It sounds like
it's more about the instrument than the method
itself. In a way, yes. It's about making sure
the entire analytical system, the instrument,
the columns, the reagents, everything is working
properly before we run our actual samples. Okay,
so it's kind of like a pre -flight check. That's
a good analogy. We use standard samples to verify
that everything is functioning correctly. We
look at things like the resolution between peaks,
the reproducibility of injections, stuff like
that. So it's like, before we set out on our
analytical journey, we make sure the car is running
smoothly. Precisely. And all of these parameters
we've talked about, they're not just scientific
concepts. They're also heavily regulated. Right,
right. ICH. Exactly. The International Council
for Harmonization, or ICH, plays a huge role
in setting standards for the pharmaceutical industry.
And they have specific guidelines for analytical
method validation, right? They do. ICH Q2R1 is
the key one. It provides detailed recommendations
on how to validate analytical methods for different
applications, like identity testing, assays,
impurity testing, and more. And following these
guidelines is important for regulatory submissions,
right? Absolutely. When a company wants to get
a new drug approved, They have to submit a ton
of data to regulatory agencies like the FDA.
And that data has to be generated using validated
methods. So following ICH guidelines helps ensure
that the data will be accepted by regulators
worldwide. It's like speaking the same language,
making sure everyone's on the same page. Exactly.
It streamlines the whole process. And of course,
regulatory agencies like the FDA, they have their
own specific expectations as well. I mean, we
don't need to get into the nitty gritty of regulations
like the Code of Federal Regulations right now.
But the point is method validation isn't just
about good science. It's also a regulatory requirement.
OK. So we've talked about the what and the why.
of method validation and the regulatory aspects.
But what about the real world impact? How does
all this translate into actual outcomes for patients?
Well, first and foremost, strong method validation
is absolutely essential for getting new drugs
approved. When a company submits an application
for a new drug, they need to demonstrate that
the drug is safe, effective, and of high quality.
And that all relies on analytical data. If the
methods used to generate that data aren't properly
validated, well, the regulators are going to
have a lot of questions. can delay the approval
process or even lead to rejection. So good validation
is basically a prerequisite for getting a drug
to market. It is. Regulators need to be confident
in the data, and validation provides that confidence.
And beyond approvals, robust validation can also
help prevent compliance issues down the line.
If a company's methods are found to be inadequate
during an inspection, it can lead to warning
letters, investigations, delays, all sorts of
headaches. And imagine that if the methods aren't
reliable, it could even lead to, like, product
recalls. Absolutely. If a bad batch of drug gets
released because of faulty analytical testing,
the consequences can be serious. You could have
patients taking a drug that's not what it's supposed
to be, and that's a huge risk. Right. That's
where the real world impact really hits home.
It does. And you know, while the specific sources
we're looking at today don't have a lot of detailed
examples of, like, specific cases of validation
successes or failures, it's important to remember
that everything we've talked about today, all
these parameters, all this rigor, it all feeds
into the bigger picture of drug development.
Yeah, it's the foundation. Exactly. And when
you see a new drug get approved or a company
consistently producing high quality medicines,
it's because of things like analytical method
validation. It's kind of like the unsung hero
of the whole process. It really is. So to sum
it all up for our listeners, analytical method
validation is a fundamental process in the pharmaceutical
industry. It's about proving beyond a doubt that
the methods we use to test drugs are reliable
and accurate. It involves a whole bunch of parameters.
It's heavily regulated and it has a huge impact
on the quality of the medicines we all rely on.
Yeah, this deep dive has definitely been eye
opening. I feel like I have a much better understanding
of why this seemingly technical area is so important.
I'm glad to hear that. It really is crucial.
And, you know, when you think about the level
of scrutiny and rigor involved in validating
these analytical methods, it really speaks to
the level of care that goes into developing new
medicines. It does. It's a reminder that there's
a lot happening behind the scenes to ensure that
the drugs we take are safe and effective. Exactly.
And we hope this deep dive has shed some light
on that process for you. If you have any questions
or if there are other areas you'd like us to
explore in future deep dives, please don't hesitate
to let us know. Yeah, we're always happy to go
deeper. Thanks for joining us for this one. It
was my pleasure. Thanks for having me. All right,
until next time. See you then.